GlassScriptPhysician profile
Sandra J Spender
NPI 1891837340
$17,057.37
in general payments reported to CMS, 2019-2025
15 companies · $4,769 in 2025
The $4,769 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,514 · 2020: $2,064 · 2021: $1,309 · 2022: $1,561 · 2023: $1,130 · 2024: $2,710 · 2025: $4,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,890 · Consulting Fee: $2,250 · Travel and Lodging: $1,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,890.45 |
| Consulting Fee | $2,250.00 |
| Travel and Lodging | $1,469.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,995.23 | 2019-2025 | Myday Contact Lens, Cvi Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $4,919.87 | 2022-2025 | Infuse, Alden Scleral Zenlens, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,166.29 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $966.97 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $681.04 | 2020-2025 | Total30, Acrysof Iq Vivity, Precision7 |
| Optos, INC. | $463.68 | 2020 | |
| Sight Sciences, INC. | $132.43 | 2021 | |
| Abbvie INC. | $124.99 | 2023 | Vuity |
| Topcon Healthcare, INC. | $124.94 | 2019-2024 | |
| Astellas Pharma US INC | $121.84 | 2025 | Izervay |
| Horizon Therapeutics Plc | $103.96 | 2021 | |
| Oyster Point Pharma, INC. | $97.57 | 2022 | |
| Optovue, INC. | $85.72 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $54.79 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $18.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Spender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.